APOM and type 2 diabetes mellitus: Plasma levels of apoM were also decreased in maturity-onset diabetes of the young (MODY3) subjects, might attribute to the hepatocyte nuclear factor-1α (HNF-1α)-dependent impairment of apoM expression leaded by heterozygous HNF-1α mutations [35, 36].